Repositioning Quinacrine Toward Treatment of Ovarian Cancer by Rational Combination With TRAIL

Quinacrine has been identified as a potent DR5-inducing agent that sensitizes cancer cells to TRAIL-induced apoptosis. In the current study, we found that quinacrine increased DR5 mRNA levels significantly in ovarian cancer cell lines regardless of p53 status. Further study showed the half-life of D...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Rui, Yao, Yuanfei, Wang, Guangyu, Yue, Er, Yang, Guangchao, Qi, Xiuying, Wang, Yang, Zhao, Ling, Zheng, Tongsen, Zhang, Yanqiao, Wenge Wang, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379129/
https://www.ncbi.nlm.nih.gov/pubmed/32766144
http://dx.doi.org/10.3389/fonc.2020.01118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379129/
https://www.ncbi.nlm.nih.gov/pubmed/32766144
http://dx.doi.org/10.3389/fonc.2020.01118

Ejemplares similares